Showing results (111-120 of 434) with videos related to
Sort By:
Pageof 44
Genome Research|May 27, 2017
Single-cell DNA sequencing reveals a late-dissemination model in metastatic colorectal cancerMarco L Leung, Alexander Davis, Ruli Gao, et al.Journal of the American College of Surgeons|February 13, 2025
Long-Term Cytoreduction Outcomes With or Without Heated Intraperitoneal Chemotherapy For Colorectal Peritoneal MetastasesMichael G White, Paula Marincola Smith, Neal Bhutiani, et al.Oncology (Williston Park, N.Y.)|October 19, 2022
Minimal Residual Disease-Directed Adjuvant Therapy for Patients With Early-Stage Colon Cancer: CIRCULATE-USIbrahim Halil Sahin, Yan Lin, Greg Yothers, et al.Cancer Metastasis Reviews|January 13, 2022
Of vascular defense, hemostasis, cancer, and platelet biology: an evolutionary perspectiveDavid G Menter, Vahid Afshar-Kharghan, John Paul Shen, et al.Journal of the American College of Surgeons|May 6, 2019
Conditional Recurrence-Free Survival after Resection of Colorectal Liver Metastases: Persistent Deleterious Association with RAS and TP53 Co-MutationYoshikuni Kawaguchi, Heather A Lillemoe, Elena Panettieri, et al.JAMA Oncology|September 12, 2024
Molecular, Socioeconomic, and Clinical Factors Affecting Racial and Ethnic Disparities in Colorectal Cancer SurvivalMahmoud Yousef, Abdelrahman Yousef, Saikat Chowdhury, et al.Cancer|April 2, 2011
Impact of BRAF mutation and microsatellite instability on the pattern of metastatic spread and prognosis in metastatic colorectal cancerBen Tran, Scott Kopetz, Jeanne Tie, et al.Cancer Investigation|September 18, 2008
Phase I clinical study of three times a day oral administration of TAS-102 in patients with solid tumorsMichael J Overman, Scott Kopetz, Gauri Varadhachary, et al.Journal of Gastrointestinal Oncology|May 13, 2022
Clinical and pathologic features correlated with rare favorable survival in patients with BRAF mutated colorectal cancerVan Morris, Bryan Kee, Michael Overman, et al.Soft Matter|July 27, 2022
Decellularized organ biomatrices facilitate quantifiable in vitro 3D cancer metastasis modelsSabrina N VandenHeuvel, Heather A Farris, Dillon A Noltensmeyer, et al.Pageof 44